Lista de obras -

Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.

artículo científico publicado en 2012

At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy

scientific article published on 27 November 2020

COVID-19 in an international European liver transplant recipient cohort

artículo científico publicado en 2020

COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry

scientific article published on 04 June 2020

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

artículo científico publicado en 2020

Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients

scientific article published on 09 June 2020

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

artículo científico publicado en 2019

Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients

artículo científico publicado en 2019

Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy

scientific article published on 12 May 2020

Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis.

artículo científico

High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

scientific article published on 11 December 2020

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients

scientific article published on 27 October 2020

Infections and Organ Transplantation

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

artículo científico publicado en 2013

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.

artículo científico publicado en 2014

Management of hepatitis C infection before and after liver transplantation

artículo científico publicado en 2015

Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C

scientific article published on 23 November 2018

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

artículo científico publicado en 2019

Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort

artículo científico publicado en 2015

Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study

scientific article published on 06 December 2019

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection

article

The societal burden of chronic liver diseases: results from the COME study.

artículo científico publicado en 2015

Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers

artículo científico publicado en 2012

Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

artículo científico publicado en 2012

Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study

artículo científico publicado en 2012

Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient

artículo científico publicado en 2007

Lista de obras de

Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.

At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy

COVID-19 in an international European liver transplant recipient cohort

COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients

Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy

Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis.

High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients

Infections and Organ Transplantation

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.

Management of hepatitis C infection before and after liver transplantation

Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort

Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection

The societal burden of chronic liver diseases: results from the COME study.

Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers

Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study

Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient